Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes

American Heart Journal

Volumn 168, Issue 1, 2014, Pages 30-36

  Stienen, Susan ^a   Salah, Khibar ^a   Moons, Andreas H M ^b   Bakx, Adrianus L M ^c   Van Pol, Petra E ^d   Schroeder Tanka, Jutta M ^e   Voogel, Albertus J ^f   Keijer, Jan T ^b   Kortz, R A Mikael ^b   Dickhoff, Cathelijne ^a   Meregalli, Paola G ^a   Tijssen, Jan G ^a   Pinto, Yigal M ^a   Kok, Wouter E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Department of Cardiology Slotervaartziekenhuis ^*  (Netherlands)

^c BovenIJ Ziekenhuis   (Netherlands)

^d RIJNLAND HOSPITAL   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^f Infection and Immunology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART FAILURE; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DRUG TARGETING; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; CAUSE OF DEATH; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; MOLECULAR TARGETED THERAPY; NATRIURETIC PEPTIDE, BRAIN; NETHERLANDS; PATIENT READMISSION; PEPTIDE FRAGMENTS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE; TIME FACTORS;

EID: 84903219132     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.04.008     Document Type: Article

References (30)

1. H.M. Krumholz, Y.T. Chen, and Y. Wang et al. Predictors of readmission among elderly survivors of admission with heart failure Am Heart J 139 2000 72 77 (Pubitemid 30043627)
2. G.A. Haldeman, J.B. Croft, and W.H. Giles et al. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995 Am Heart J 137 1999 352 360 (Pubitemid 29070149)
3. P. Bettencourt, A. Ferreira, and P. Dias et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure Cardiology 93 2000 19 25 (Pubitemid 30436406)
4. F.D. Hobbs, R.C. Davis, and A.K. Roalfe et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations BMJ 324 2002 1498
5. J.G. Lainchbury, E. Campbell, and C.M. Frampton et al. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath J Am Coll Cardiol 42 2003 728 735 (Pubitemid 37000195)
6. K. Maeda, T. Tsutamoto, and A. Wada et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825 832 (Pubitemid 28237306)
7. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167 (Pubitemid 34764819)
8. T. Tsutamoto, A. Wada, and K. Maeda et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516 (Pubitemid 27329427)
9. R. Berger, D. Moertl, and S. Peter et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure: a 3-arm, prospective, randomized pilot study J Am Coll Cardiol 55 2010 645 653
10. L.W. Eurlings, P.E. van Pol, and W.E. Kok et al. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study J Am Coll Cardiol 56 2010 2090 2100
11. J.L. Januzzi Jr., S.U. Rehman, and A.A. Mohammed et al. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 2011 1881 1889
12. J.G. Lainchbury, R.W. Troughton, and K.M. Strangman et al. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial J Am Coll Cardiol 55 2009 53 60
13. M. Pfisterer, P. Buser, and H. Rickli et al. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial JAMA 301 2009 383 392
14. H. Persson, H. Erntell, and B. Eriksson et al. Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure-SIGNAL-HF (Swedish Intervention study-Guidelines and NT-proBNP AnaLysis in Heart Failure) Eur J Heart Fail 12 2010 1300 1308
15. R.W. Troughton, C.M. Frampton, and T.G. Yandle et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130 (Pubitemid 30172933)
16. A. Bayes-Genis, L. Lopez, and E. Zapico et al. NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality J Card Fail 11 2005 S3 S8
17. P. Bettencourt, A. Azevedo, and J. Pimenta et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2004 2168 2174 (Pubitemid 39372496)
18. D. Logeart, G. Thabut, and P. Jourdain et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure J Am Coll Cardiol 43 2004 635 641 (Pubitemid 38229537)
19. V. Verdiani, A. Ognibene, and M.S. Rutili et al. NT-ProBNP reduction percentage during hospital stay predicts long-term mortality and readmission in heart failure patients J Cardiovasc Med (Hagerstown) 9 2008 694 699
20. F. Zannad, A.A. Garcia, and S.D. Anker et al. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document Eur J Heart Fail 15 2013 1082 1094
21. J.L. Januzzi, J. Lainchbury, and K.R. van et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337 (Pubitemid 43100029)
22. T.S. Rector, S.H. Kubo, and J.N. Cohn Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo Am J Cardiol 71 1993 1106 1107 (Pubitemid 23126823)
23. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
24. L. Beck-da-Silva, B.A. de, and M. Fraser et al. BNP-guided therapy not better than expert's clinical assessment for beta-blocker titration in patients with heart failure Congest Heart Fail 11 2005 248 253
25. P. Jourdain, G. Jondeau, and F. Funck et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study J Am Coll Cardiol 49 2007 1733 1739 (Pubitemid 46589928)
26. J.P. Piccini, A.F. Hernandez, and D. Dai et al. Use of cardiac resynchronization therapy in patients hospitalized with heart failure Circulation 118 2008 926 933
27. J.D. Flaherty, J.S. Rossi, and G.C. Fonarow et al. Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J 157 2009 1018 1025
28. D. Roy, M. Talajic, and S. Nattel et al. Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677 (Pubitemid 351860859)
29. G.C. Fonarow, and E. Corday Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry Heart Fail Rev 9 2004 179 185 (Pubitemid 40521279)
30. A. Maisel Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design? J Am Coll Cardiol 55 2009 61 64